好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Longitudinal Change in Diffusion Kurtosis Imaging Metrics as a Biomarker of Mild Traumatic Brain Injury.
Neuro Trauma, Critical Care, and Sports Neurology
P3 - Poster Session 3 (5:30 PM-6:30 PM)
4-029

To determine the utility of diffusion kurtosis imaging (DKI) as an advanced neuroimaging biomarker for Mild Traumatic Brain Injury (mTBI).

In the absence of structural abnormalities in mTBI, diffusion tensor imaging (DTI) metrics are often inadequate to determine longitudinal changes in microstructural white matter integrity. DKI extends conventional DTI for greater sensitivity and specificity of microstructural axonal injury.

111 mTBI patients and 32 controls (15-50 years old) were enrolled acutely after mTBI and followed with up to 4 standardized serial assessments over 3 months. Patients were enrolled at either Encounter 1 (E1), within 72 hours, or Encounter 2 (E2), 5-10 days post-injury, and returned for Encounter 3 (E3) at 15-29 days and Encounter 4 (E4) at 83-97 days. Each encounter included a clinical exam, neuropsychological assessment, as well as diffusion kurtosis imaging. Data were analyzed as mean percentage of diffusion kurtosis orthogonal outlier within each region of interest. Voxels were considered an outlier if orthogonal kurtosis was >99.5% percentile of the healthy control distribution.

Within mTBI subjects, mean percentage of orthogonal kurtosis imaging (Korth) outliers was significantly greater at E1-E3 relative to E4 (p<.05). Between-subjects analysis revealed a significant difference in mean percentage of Korth outliers at E2 between mTBI and controls (p<.05). Furthermore, rank-sum test of regions of interest (ROI) sorted by ROIs with the greatest number of outliers at E2, identified a subset of 20 regions that differed acutely between mTBI and controls.  

Diffusion kurtosis imaging was sensitive to longitudinal changes in white matter integrity. Additionally, mean percentage of Korth outliers in a subset of 20 ROIs may serve as a potential mTBI diagnostic marker.

Authors/Disclosures
Teena Shetty, MD, FAAN (Hospital for Special Surgery)
PRESENTER
Dr. Shetty has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for mTBI, Inc. The institution of Dr. Shetty has received research support from Marker AG. The institution of Dr. Shetty has received research support from GE-NFL.
Joseph T Nguyen Joseph T Nguyen has nothing to disclose.
Esther Kim, NP (Columbia University/Neurological Institute) No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
No disclosure on file
Kristin Halvorsen (Hospital for Special Surgery) No disclosure on file
No disclosure on file
Joseph C. Masdeu, MD, PhD, FAAN (Houston Methodist Neurological Institute) Dr. Masdeu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Lilly . The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Houston Methodist Foundation. The institution of Dr. Masdeu has received research support from Alector. The institution of Dr. Masdeu has received research support from Aviado-Bio. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
No disclosure on file
Luca Marinelli Luca Marinelli has received personal compensation for serving as an employee of General Electric.